Sexual dysfunction after cancer: gender differences, tumor-specific patterns, and implications for sexual medicine practice [0.03%]
癌症后的性功能障碍：性别差异，肿瘤特异性模式及其对性医学实践的影响
Isabella Bisceglia,Fortunato Morabito,Guglielmo Ferrari et al.
Isabella Bisceglia et al.
Background: Sexual health is a central component of wellbeing, identity, and intimate relationships, yet it remains insufficiently addressed in cancer care. Cancer treatments disrupt sexual functioning through interacting...
Barry J A Laird,Lorenzo Antonuzzo,Darío Sánchez Cabrero et al.
Barry J A Laird et al.
Background: Cancer significantly impacts nutritional status, thereby affecting treatment tolerance, quality of life, and survival. However, nutrition remains underutilized in oncology care. ...
Development and validation of a risk prediction model for chemical cystitis in patients with non-muscle-invasive bladder cancer undergoing intravesical instillation [0.03%]
膀胱内药物灌注非肌层浸润性膀胱癌患者化学性膀胱炎风险预测模型的建立和验证
Xinyu Yi,Zhaoyi Zhao,Jin Li
Xinyu Yi
Objective: To develop and validate a risk prediction model for Chemical cystitis in patients with non-muscle-invasive bladder cancer (NMIBC) undergoing intravesical instillation. ...
How recreational therapies impact physiological and psychosocial outcomes in cancer patients: a review [0.03%]
娱乐疗法对癌症患者生理及心理社会结果的影响：综述文章
Marika D&#x;Oria,Calogero Casà,Cristina Cenci et al.
Marika D&#x;Oria et al.
Recreational Therapies (RecT) (e.g., art, dance, music, yoga, aromatherapy, Virtual Reality) are non-invasive interventions capable of enhancing the biopsychosocial wellbeing in patients, targeted to regenerate the existential dimensions of...
Lorenzo Agoni,Orges Spahiu,Dukagjin M Blakaj
Lorenzo Agoni
Human papillomavirus (HPV) usually infects the anogenital and the oropharyngeal areas. HPV may lead to cancer at these sites, most notably at the uterine cervix. Less frequently, vaginal, vulvar, anal and penile cancers may also arise. HPV ...
Evaluating the role of BMI in survival and complications in older esophageal squamous cell carcinoma following esophagectomy [0.03%]
体重指数在食管癌切除术后老年食管鳞状细胞癌患者生存率和并发症中的作用评估
Kexun Li,Simiao Lu,Changding Li et al.
Kexun Li et al.
Background: To evaluate the impact of Body Mass Index (BMI) on survival and postoperative complications in older patients with esophageal squamous cell carcinoma (ESCC) following esophagectomy, we designed this study. ...
Yangzheng Zhang,Weidong Liu
Yangzheng Zhang
This review focuses on the CALLY index in cancer, exploring its theoretical foundations, epidemiological insights, diagnostic and prognostic applications, therapeutic implications, controversies, and future perspectives. The CALLY index, ba...
Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody-drug conjugate in breast cancer [0.03%]
新型抗体药物偶联物靶向TROP-2的单克隆抗体索ivantumab-tirretinclis（IMMU-132）在乳腺癌中的应用
Amalia A Sofianidi,Alkistis Papatheodoridi,Constantine Dimitrakakis et al.
Amalia A Sofianidi et al.
The discovery of antibody-drug conjugates (ADCs) has revolutionized the therapeutic landscape of oncology patients, especially those suffering from breast cancer. Following the approval of the first ADC for solid tumors in breast cancer, nu...
A new paradigm for retroperitoneal leiomyosarcoma: integrating transcriptomic subtyping and surgical risk stratification for AI-guided drug repurposing [0.03%]
后腹膜平滑肌肉瘤的新范式：整合转录组亚型分层和手术风险分层以指导AI辅助的药物再利用
Nan Jia,Zicheng Bao,Zhidong Zhang et al.
Nan Jia et al.
Retroperitoneal leiomyosarcoma (RLMS) remains a major therapeutic challenge because of frequent postoperative recurrence and the limited benefit of current adjuvant therapies. The marked molecular heterogeneity of RLMS and its incompletely ...
Gut microbiota-immunity cascade in hepatocellular carcinoma: mechanisms and therapeutic opportunities [0.03%]
肝细胞癌中肠道微生物群-免疫级联反应：机制与治疗机会
Jihao Yang,Yishuang Dai,Jia Li
Jihao Yang
Hepatocellular carcinoma (HCC) constitutes a major global health burden, with limited responsiveness to current immunotherapeutic regimens. Accumulating evidence underscores the gut microbiota as a crucial regulator of the gut-liver axis, m...